Safety, Tolerability and Efficacy of a Topical Treatment (SM04554) for Androgenetic Alopecia (AGA): Results from a Phase 2 Trial
https://www.samumed.com/files/2016/sm04554aga02_latebreakingabstract_aad2016_20151215_Final.pdf
https://www.samumed.com/files/2016/Samumed_AGA_Phase_2_OP_20160225_final_3-1-16.pdf
https://www.samumed.com/files/2016/sm04554aga02_latebreakingabstract_aad2016_20151215_Final.pdf
https://www.samumed.com/files/2016/Samumed_AGA_Phase_2_OP_20160225_final_3-1-16.pdf